Who Exports Salicylic from India — 276 Suppliers Behind a $16.8M Market
India's salicylic export market is supplied by 276 active exporters who collectively shipped $16.8M across 2,799 shipments. RECKITT BENCKISER (INDIA) PRIVATE LIMITED leads with a 21.5% market share, followed by RECKITT BENCKISER INDIA PRIVATE LIMITED and CIPLA LIMITED. The top 5 suppliers together control 59.0% of total export value, reflecting a moderately competitive market structure.
Top Salicylic Exporters from India — Ranked by Export Value
RECKITT BENCKISER (INDIA) PRIVATE LIMITED is the leading salicylic exporter from India, holding a 21.5% share of the $16.8M market across 2,799 shipments from 276 exporters. The top 5 suppliers — RECKITT BENCKISER (INDIA) PRIVATE LIMITED, RECKITT BENCKISER INDIA PRIVATE LIMITED, CIPLA LIMITED, UNILINK PHARMA PRIVATE LIMITED, MEDREICH LIMITED — collectively control 59.0% of total export value, indicating a moderately concentrated market. Individual shares are: RECKITT BENCKISER (INDIA) PRIVATE LIMITED (21.5%), RECKITT BENCKISER INDIA PRIVATE LIMITED (13.1%), CIPLA LIMITED (11.7%), UNILINK PHARMA PRIVATE LIMITED (6.7%), MEDREICH LIMITED (6.0%).
Top Salicylic Exporters from India
Ranked by export value · 276 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | RECKITT BENCKISER (INDIA) PRIVATE LIMITED | $3.6M | 2 | 21.5% |
| 2 | RECKITT BENCKISER INDIA PRIVATE LIMITED | $2.2M | 1 | 13.1% |
| 3 | CIPLA LIMITED ALSIN-100 TABLETSETHICS ASPIRIN ENTERIC COATED 100 MG TABLET - CI02058 (INV. | $2.0M | 3 | 11.7% |
| 4 | UNILINK PHARMA PRIVATE LIMITED BENZOIC ACID AND SALICYLIC ACID OINTMENTACETYLSALICYLIC ACID 300MG TBENZOIC ACID WITH SALICYLIC ACID OINMENT | $1.1M | 2 | 6.7% |
| 5 | MEDREICH LIMITED ACETYL SALICYLIC ACID 75MG TABLETS 1X28SACETYL SALICYLIC ACID 75MG TABLETS (ACTUACETYL SALICYLIC ACID 75 MG TABLETS 1X28 | $1.0M | 9 | 6.0% |
| 6 | AUROBINDO PHARMA LTD ACETYLSALICYLIC ACID TABLETS 80MG(ACETYLACETYLSALICYLIC ACID TABLETS 80MGACETYL SALICYLIC ACID 75MG TABLETS (ACTU | $745.3K | 2 | 4.4% |
| 7 | ACME GENERICS PRIVATE LIMITED PRO-AAS EC-80(ACETYLSALICYLIC ACID DELAYACETYL SALICYLIC ACID CHEWABLE TABS 80MG | $686.1K | 1 | 4.1% |
| 8 | DR REDDY S LABORATORIES LIMITED ACETYL SALICYLIC ACID 75MG TABLETS 1X28SACETYL SALICYLIC ACID 75MG TABLETS (ACTUACETYL SALICYLIC ACID 75 MG TABLETS 1X28 | $401.0K | 1 | 2.4% |
| 9 | MEDINOMICS HEALTH CARE PRIVATE LIMITED KILLPANE TABLETS (ACETYLSALICYLIC ACIDKILLPANE TABLETSKILLPANE TABLETS ACETYLSALICYLIC ACID 3 | $295.0K | 1 | 1.8% |
| 10 | AGIO PHARMACEUTICALS LIMITED | $281.8K | 2 | 1.7% |
| 11 | VARDHMAN EXPORTS | $273.6K | 4 | 1.6% |
| 12 | MSN LABORATORIES PRIVATE LIMITED ACETYLSALICYLIC ACID TABLETS 80MG(ACETYLACETYLSALICYLIC ACID TABLETS 80MG | $263.2K | 1 | 1.6% |
| 13 | ACME GENERICS LLP PRO-AAS EC-80(ACETYLSALICYLIC ACID DELAYACETYL SALICYLIC ACID CHEWABLE TABS 80MG | $245.0K | 1 | 1.5% |
| 14 | BHARAT PARENTERALS LIMITED BENZOIC ACID AND SALICYLIC ACID OINTMENTACETYLSALICYLIC ACID 300MG TBENZOIC ACID WITH SALICYLIC ACID OINMENT | $239.6K | 3 | 1.4% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Salicylic exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Cipla Limited | Approved | Yes, as of February | Yes | Data not available | Cipla's Baddi Unit 1 facility in Himachal Pradesh, India, was inspected by WHO i |
| Dr. Reddy's Laboratories Limited | Approved | Yes, as of April 202 | Yes | Data not available | Dr. Reddy's Molnupiravir Capsules, hard 200 mg, were prequalified by WHO in Apri |
| MSN Laboratories Private Limited | Approved | Yes, as of July 2020 | Yes | Data not available | MSN's Oseltamivir 45mg Capsules were prequalified by WHO in July 2020. (extranet |
| Glenmark Pharmaceuticals Limited | Warning Letter, July 2025 | Data not available | Data not availa | Data not available | FDA issued a warning letter to Glenmark's Pithampur facility in July 2025 for CG |
| Mylan Laboratories Limited (Viatris, Inc.) | Warning Letter, December | Yes, as of March 202 | Data not availa | Data not available | FDA issued a warning letter to Mylan's Indore facility in December 2024; WHO con |
TransData Nexus reviewed the regulatory standing of 5 leading Salicylic exporters from India. 3 hold US FDA facility approvals, 4 maintain WHO-GMP certification, and 3 are EU GMP compliant. 2 suppliers have received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Salicylic sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," hosts over 800 pharmaceutical companies, including major players like Dr. Reddy's Laboratories and Aurobindo Pharma. The city's Genome Valley is India's first biotech cluster, providing advanced R&D infrastructure and a skilled talent pool from institutions such as the National Institute of Pharmaceutical Education and Research (NIPER) and the Indian Institute of Chemical Technology (IICT). This robust ecosystem supports the production of active pharmaceutical ingredients (APIs), vaccines, biologics, and biosimilars, making Hyderabad a pivotal hub for pharmaceutical manufacturing and innovation.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is a significant center for pharmaceutical formulations, contributing nearly 28% of India's pharmaceutical production. This region is home to prominent companies such as Zydus Cadila, Intas Pharmaceuticals, and Torrent Pharmaceuticals. The well-established infrastructure, including ports, roads, and utilities, coupled with a strong regulatory framework, facilitates efficient manufacturing and distribution of pharmaceutical products. The presence of numerous formulation units underscores the region's importance in the pharmaceutical supply chain.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt in Maharashtra serves as a crucial export gateway for India's pharmaceutical industry. With 929 pharmaceutical units, the region boasts a well-developed infrastructure, including major ports and international airports, facilitating seamless export operations. The proximity to regulatory bodies and a vast talent pool further enhance the region's appeal for pharmaceutical manufacturing and export activities.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi, located in Himachal Pradesh, has emerged as Asia's largest pharmaceutical hub, housing over 1,000 manufacturing units. The region's growth is attributed to favorable government policies, including tax incentives and exemptions, which have attracted numerous pharmaceutical companies. Baddi's strategic location near Chandigarh and its robust infrastructure make it a preferred destination for pharmaceutical manufacturing.
5Sourcing Recommendations
- Diversify Supplier Base: To mitigate risks associated with supplier concentration, consider engaging with multiple suppliers across different regions, including Hyderabad, Ahmedabad-Vadodara, and Baddi.
- Leverage Regional Strengths: Utilize Hyderabad's expertise in API production, Ahmedabad-Vadodara's capabilities in formulations, and Baddi's cost advantages due to tax incentives to optimize the supply chain.
- Ensure Regulatory Compliance: Collaborate with suppliers who adhere to international quality standards and possess necessary certifications to ensure product quality and facilitate smooth export processes.
- Monitor Export Destinations: Given the significant export volumes to countries like South Africa and Guinea, align sourcing strategies to meet the specific regulatory and market requirements of these regions.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Salicylic exporters from India
Reckitt Benckiser Group Plc — Reckitt Benckiser sells homecare brands to Advent for $4.8 billion
Reckitt Benckiser Group Plc agreed to sell most of its homecare business to private equity firm Advent International for an enterprise value of up to $4.8 billion. The deal includes brands such as Air Wick and Cillit Bang, with Reckitt retaining a 30% stake in the business. - IMPACT: This divestiture allows Reckitt to focus more on its consumer health and hygiene segments, potentially affecting its product portfolio and export strategies, including those related to salicylic acid.
Impact: This divestiture allows Reckitt to focus more on its consumer health and hygiene segments, potentially affecting its product portfolio and export strategies, including those related to salicylic acid.
Reckitt Benckiser Healthcare India Pvt. Ltd. and Cipla Ltd. — Reckitt Benckiser and Cipla settle advertisement dispute
Reckitt Benckiser Healthcare India Pvt. Ltd. filed a civil suit against Cipla Ltd., alleging that Cipla's advertisement disparaged Reckitt's product, MOOV. During the proceedings, both parties reached a compromise, with Cipla agreeing to refrain from using certain portions of the advertisement and specific claims related to its product, OMNIGEL. - IMPACT: The resolution of this dispute may lead to improved relations between the two companies, potentially influencing collaborative efforts or competitive dynamics in the salicylic acid market.
Impact: The resolution of this dispute may lead to improved relations between the two companies, potentially influencing collaborative efforts or competitive dynamics in the salicylic acid market.
Cipla Limited — Cipla among bidders for Wellbeing Nutrition acquisition
Wellbeing Nutrition, backed by Hindustan Unilever Limited and Fireside Ventures, was put on the market for a strategic sale, with a valuation of around INR 15,000 million. Top pharma and FMCG companies, including Cipla, were approached as potential bidders. - IMPACT: If Cipla successfully acquires Wellbeing Nutrition, it could diversify its product offerings and strengthen its position in the health and wellness sector, potentially impacting its focus and resources allocated to salicylic acid exports.
Impact: If Cipla successfully acquires Wellbeing Nutrition, it could diversify its product offerings and strengthen its position in the health and wellness sector, potentially impacting its focus and resources allocated to salicylic acid exports.
Common Questions — Salicylic Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which salicylic supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, RECKITT BENCKISER (INDIA) PRIVATE LIMITED leads with 264 recorded shipments worth $3.6M. RECKITT BENCKISER INDIA PRIVATE LIMITED (86 shipments) and CIPLA LIMITED (121 shipments) are also established high-volume exporters.
Q How many salicylic manufacturers are there in India?
India has 276 active salicylic exporters with a combined export market of $16.8M across 2,799 shipments to 132 countries. The top 5 suppliers hold 59.0% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for salicylic from India?
Average FOB unit price: $2.42 per unit, ranging from $0.00 to $103.92. Average shipment value: $6.0K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 276 verified Indian exporters of Salicylic ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 2,799 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 132 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2,799 Verified Shipments
276 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists